IDH1 and central nervous system cancer: To determine if this prognostic classifier could perform as an independent indicator in gliomas, a nomogram that integrated lncRNAs classifiers and clinicopathological characteristics, including age, IDH mutation, 1p/19q, and the WHO grade, was constructed to estimate the 3- and 5-year survival rate in glioma patients (Figure 5A).